Recent advancements in GLP-1 drugs, such as Ozempic and Wegovy, underscore their potential to transform health care by addressing obesity, cardiovascular diseases and even neurodegenerative ...

PDS Biotechnology (NASDAQ: PDSB) was able to submit an IND to begin its phase 3 VERSATILE-003 study, using PDS0101 + KEYTRUDA to treat patients with recurrent or metastatic head and neck squamous ...

Scientists have recently discovered an innovative approach to data storage by harnessing the natural capabilities of DNA.

For example, BBH is higher by almost 11% over the past month. That could be the beginning of something more substantial for the ETF, particularly if AI advancements further penetrate the biotech ...

According to MarketsandMarkets, the global enzymes market is experiencing robust growth, driven by innovations in biotechnology, increasing demand in biopharmaceutical production, and rising ...

Please provide your email address to receive an email when new articles are posted on . In this episode, host Shikha Jain, MD, speaks with Cyclacel CEO, Spiro Rombotis, MPH, about developing ...

Global Agri-Food Advancement Partnership (GAAP) Invests in Biotech Startup Proxima Research & Development January 15, 2024 03:28 PM Eastern Standard Time ...

Fortress Biotech (FBIO – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Joseph Pantginis from H.C. Wainwright reiterated a Buy rating on ...

Oncolytics Biotech ( ($ONCY) ) has released its Q2 earnings. Here is a breakdown of the information Oncolytics Biotech presented to its investors.

Purple Biotech has successfully closed a $2.8 million registered direct offering of American Depositary Shares, with H.C. Wainwright & Co. acting as the exclusive placement agent. The funds will ...

Analyst Joseph Pantginis of H.C. Wainwright reiterated a Buy rating on Krystal Biotech (KRYS – Research Report), retaining the price target of $221.00. Pick the best stocks and maximize your ...